TY - JOUR
T1 - Plasma kynurenine and related measures in tic disorder patients
AU - Hoekstra, Pieter J.
AU - Anderson, George M.
AU - Troost, Pieter W.
AU - Kallenberg, Cees G. M.
AU - Minderaa, Ruud B.
N1 - Article
PY - 2007/6
Y1 - 2007/6
N2 - Objective Increased plasma kynurenine has been reported in tic disorder patients, and this observation has been suggested to be indicative of immune dysregulation. In the present study, we examined plasma levels of kynurenine and related molecules in a group of tic disorder patients. Methods Plasma concentrations of tryptophan, kynurenine, cortisol, and neopterin were determined in Dutch tic disorder patients (N = 59), and healthy volunteers (N = 32). Group means were compared and age-controlled intra-individual correlations between tic severity and plasma levels of these molecules were examined. Results No significant differences were found between patient and control groups in plasma levels of tryptophan, kynurenine, and cortisol concentrations, nor in the kynurenine/tryptophan ratio. However, neopterin was significantly (p = 0.035) higher in patients (mean = 5.13 nmol/1) than in controls (mean = 3.30 nmol/1). Plasma levels of these molecules did not correlate with tic severity, with the exception of tryptophan (r = -0.289, p = 0.049). In patients, plasma neopterin correlated with kynurenine (r = 0.438, P = 0.002); in healthy subjects, tryptophan correlated with kynurenine (r = 0.670, p <0.00 1). Conclusion While the observed elevation in plasma neopterin is consistent with immune activation in a subset of tic disorder patients, metabolism of tryptophan through the kynurenine pathway appears to be unaltered in tic disorder patients.
AB - Objective Increased plasma kynurenine has been reported in tic disorder patients, and this observation has been suggested to be indicative of immune dysregulation. In the present study, we examined plasma levels of kynurenine and related molecules in a group of tic disorder patients. Methods Plasma concentrations of tryptophan, kynurenine, cortisol, and neopterin were determined in Dutch tic disorder patients (N = 59), and healthy volunteers (N = 32). Group means were compared and age-controlled intra-individual correlations between tic severity and plasma levels of these molecules were examined. Results No significant differences were found between patient and control groups in plasma levels of tryptophan, kynurenine, and cortisol concentrations, nor in the kynurenine/tryptophan ratio. However, neopterin was significantly (p = 0.035) higher in patients (mean = 5.13 nmol/1) than in controls (mean = 3.30 nmol/1). Plasma levels of these molecules did not correlate with tic severity, with the exception of tryptophan (r = -0.289, p = 0.049). In patients, plasma neopterin correlated with kynurenine (r = 0.438, P = 0.002); in healthy subjects, tryptophan correlated with kynurenine (r = 0.670, p <0.00 1). Conclusion While the observed elevation in plasma neopterin is consistent with immune activation in a subset of tic disorder patients, metabolism of tryptophan through the kynurenine pathway appears to be unaltered in tic disorder patients.
KW - tic disorders
KW - kynurenine
KW - tryptophan
KW - neopterin
KW - indoleamine 2,3-dioxygenase
KW - cortisol
KW - OBSESSIVE-COMPULSIVE DISORDER
KW - TOURETTES-SYNDROME
KW - STREPTOCOCCAL INFECTIONS
KW - NEOPTERIN CONCENTRATIONS
KW - DIFFERENTIATE PANDAS
KW - PEDIATRIC POPULATION
KW - SERUM AUTOANTIBODIES
KW - CEREBROSPINAL-FLUID
KW - SYDENHAMS CHOREA
KW - BLOOD SEROTONIN
U2 - 10.1007/s00787-007-1009-1
DO - 10.1007/s00787-007-1009-1
M3 - Article
SN - 1018-8827
VL - 16
SP - 71
EP - 77
JO - European Child & Adolescent Psychiatry
JF - European Child & Adolescent Psychiatry
IS - Suppl. 1
ER -